% Expired Patents = 20.0

CIPO Patents = 4

Trademarks = 39

Forward Citations = 25

Loading Chart...

5 inventors (with patents filed for the assignee):

Stéphane De Lombaert (5 out of 13 patents)

Daniel R Goldberg (5 out of 53 patents)

Kenneth Albert Brameld (4 out of 27 patents)

4. Andrew Scribner (4 out of 12 patents)

5. Eric Brian Sjogren (4 out of 64 patents)

6. Stephane De Lombaert (15 patents)

5 patents: Sort by Forward Citations

1. 10946018 - Spirocyclic compounds as tryptophan hydroxylase inhibitors (2021-03-16),

2. 10710948 - Processes for preparing (R)-1-(5-chloro-[1,1″-biphenyl] -2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1″-biphenyl]-2-yl)-2,2,2-trifluoroethanone (2020-07-14),

3. 10660893 - Spirocyclic compounds as tryptophan hydroxylase inhibitors (2020-05-26),

4. 10350208 - Spirocyclic compounds as tryptophan hydroxylase inhibitors (2019-07-16),

5. 10045988 - Spirocyclic compounds as tryptophan hydroxylase inhibitors (2018-08-14),

Roivant Sciences is a global biopharmaceutical company focused on realizing the full potential of promising biomedical research. They aim to develop and commercialize innovative therapies across a range of therapeutic areas, improving the lives of patients worldwide. Roivant operates a unique and data-driven model that enables efficient drug development and delivery to market.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

5 Patents

#64 in Basel

#1,705 in Switzerland

Basel, Switzerland

Roivant Sciences Gmbh